Affiliation:
1. The State Budgetary Healthcare Institution of the Moscow Region Moscow Regional Research Institute of Obstetrics and Gynecology;
Russian Association on Thrombosis, Haemostasis and Vascular Pathology named after A. Schmidt–B. Kudryashov
2. The State Budgetary Healthcare Institution of the Moscow Region Moscow Regional Research Institute of Obstetrics and Gynecology
3. Russian Association on Thrombosis, Haemostasis and Vascular Pathology named after A. Schmidt–B. Kudryashov
Abstract
The rate of thromboembolic complications associated with thrombophilia is very high; therefore the detection of thrombophilia mutations in the high-risk group of patients is important for the prevention of morbidity, mortality and obstetric losses. The problem of thrombophilia is dealt with by doctors of various specialties: laboratory stuff, geneticists, vascular surgeons, hematologists, neurologists, cardiologists and obstetricians-gynecologists. At the same time, patients with spontaneous thrombosis are followed-up for years without proper examination for thrombophilia. Considering that pregnancy is a condition associated with a high probability of re-thrombosis, it is advisable to determine the cause and tactics of management and treatment of pregnant women as early as possible during the period of pregnancy.
Publisher
Medical Informational Agency Publishers
Reference36 articles.
1. Petrukhin V.A., Melnikov A.P., Budykina T.S., Ratnikov A.O. Possibilities of laboratory control of preventive doses of heparin in obstetric practice. Proceedings of the XXI National Congress with International Participation «Thrombosis, bleeding, and permanent intravascular coagulation» on October 11–13, 2017 in St. Petersburg. 2017;43–44. (in Russian.)
2. Bates S.M., Greer I.A., Middeldorp S. et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic therapy and prevention of thrombosis 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141:691–736.
3. Grandone E., Tomaiuolo M., Colaizzo D. et al. Role of thrombophilia in adverse obstetric outcomes and their prevention using anti thrombotic therapy. Semin. Thromb. Hemost. 2009;35:630–43.
4. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb. Diath. Haemorrh. 1965;13:516–30. Cited by I.N. Bokarev «Hematology for a practical doctor». MIA, Moscow. 2018:227. (in Russian.)
5. Franco R.F., Reitsma P.H. Genetic risk factors of venous thrombosis. Hum. Genet. 2001;109:369–84.